Lenalidomide in the Treatment of Mucosal Behçet's Syndrome
NCT05449548
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Oral Ulcer
Interventions
DRUG:
Lenalidomide 10 mg
Sponsor
Peking Union Medical College Hospital